Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics?

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Predictive Importance of Blood Pressure Characteristics With Increasing Age in Healthy Men and Women: The MORGAM Project

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Antihypertensive Drugs and Risk of Depression: A Nationwide Population-Based Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Does Estimated Pulse Wave Velocity Add Prognostic Information? MORGAM Prospective Cohort Project

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Risk of Developing Hypokalemia in Patients With Hypertension Treated With Combination Antihypertensive Therapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Finerenone and Cardiovascular Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Effect of Dapagliflozin on Clinical Outcomes in Patients with Chronic Kidney Disease, With and Without Cardiovascular Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Antonia Vlahou
  • Dara Hallinan
  • Rolf Apweiler
  • Angel Argiles
  • Joachim Beige
  • Ariela Benigni
  • Rainer Bischoff
  • Peter C Black
  • Franziska Boehm
  • Jocelyn Céraline
  • George P Chrousos
  • Christian Delles
  • Pieter Evenepoel
  • Ivo Fridolin
  • Griet Glorieux
  • Alain J van Gool
  • Isabel Heidegger
  • John P A Ioannidis
  • Joachim Jankowski
  • Vera Jankowski
  • Carmen Jeronimo
  • Ashish M Kamat
  • Rosalinde Masereeuw
  • Gert Mayer
  • Harald Mischak
  • Alberto Ortiz
  • Giuseppe Remuzzi
  • Peter Rossing
  • Joost P Schanstra
  • Bernd J Schmitz-Dräger
  • Goce Spasovski
  • Jan A Staessen
  • Dimitrios Stamatialis
  • Peter Stenvinkel
  • Christoph Wanner
  • Stephen B Williams
  • Faiez Zannad
  • Carmine Zoccali
  • Raymond Vanholder
View graph of relations

The General Data Protection Regulation (GDPR) became binding law in the European Union Member States in 2018, as a step toward harmonizing personal data protection legislation in the European Union. The Regulation governs almost all types of personal data processing, hence, also, those pertaining to biomedical research. The purpose of this article is to highlight the main practical issues related to data and biological sample sharing that biomedical researchers face regularly, and to specify how these are addressed in the context of GDPR, after consulting with ethics/legal experts. We identify areas in which clarifications of the GDPR are needed, particularly those related to consent requirements by study participants. Amendments should target the following: (1) restricting exceptions based on national laws and increasing harmonization, (2) confirming the concept of broad consent, and (3) defining a roadmap for secondary use of data. These changes will be achieved by acknowledged learned societies in the field taking the lead in preparing a document giving guidance for the optimal interpretation of the GDPR, which will be finalized following a period of commenting by a broad multistakeholder audience. In parallel, promoting engagement and education of the public in the relevant issues (such as different consent types or residual risk for re-identification), on both local/national and international levels, is considered critical for advancement. We hope that this article will open this broad discussion involving all major stakeholders, toward optimizing the GDPR and allowing a harmonized transnational research approach.

Original languageEnglish
JournalHypertension
Volume77
Issue number4
Pages (from-to)1029-1035
Number of pages7
ISSN0194-911X
DOIs
Publication statusPublished - Apr 2021

ID: 64864018